Role of dehydroepiandrosterone in management of glucocorticoid-induced secondary osteoporosis in female rats
- 1 September 2012
- journal article
- Published by Elsevier in Experimental and Toxicologic Pathology
- Vol. 64 (6) , 659-664
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Glucocorticoid‐induced bone fragilityAnnals of the New York Academy of Sciences, 2010
- Potential new drug targets for osteoporosisNature Clinical Practice Rheumatology, 2009
- The effects of dexamethasone and dehydroepiandrosterone (DHEA) on cytokines and receptor expression in a human osteoblastic cell line: Potential steroid-sparing role for DHEACytokine, 2006
- OsteopetrosisNew England Journal of Medicine, 2004
- Glucocorticoid Suppression of IGF I Transcription in OsteoblastsMolecular Endocrinology, 2001
- Comparison of osteopenia after gastrectomy, ovariectomy and prednisolone treatment in the young female ratActa Orthopaedica, 2001
- An Acute Oral Gavage Study of 3β-Acetoxyandrost- 5-ene-7,17-dione (7-oxo-DHEA-acetate) in RatsBiochemical and Biophysical Research Communications, 1999
- Regulation of parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid by glucocorticoids and PTH in ROS 17/2.8 and OK cellsEndocrinology, 1994
- Osteocalcin: Diagnostic Methods and Clinical ApplicationsCritical Reviews in Clinical Laboratory Sciences, 1991
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987